Psychogenic Nonepileptic Seizures in Children and Adolescents

Hema Patel1, Hillary Blake2, David Dunn3

  • 1Department of Neurology, Section of Pediatric Neurology, Children's Wisconsin, Medical College of Wisconsin, USA. Correspondence to: Dr Hema Patel, Professor, Clinical Neurology, Department of Pediatric Neurology, 999, North 92nd Street, Suite 540, Milwaukee, WI 53226, USA. hpatel@mcw.edu.

Indian Pediatrics
|March 13, 2021
PubMed

Insights

Psychogenic non-epileptic seizures (PNES) in children and adolescents are common, but research on their development is limited. Pediatric PNES may have better outcomes than adult cases, but more studies are needed.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Child Psychiatry

Background:

  • Psychogenic non-epileptic seizures (PNES) are frequently encountered in pediatric epilepsy evaluations.
  • Limited literature exists on developmental changes and specific characteristics of PNES in children and adolescents.

Purpose of the Study:

  • To review the existing literature on psychogenic non-epileptic seizures (PNES) in pediatric populations.
  • To summarize clinical features, predisposing factors, workup, and outcomes of PNES in children and adolescents.

Main Methods:

  • A comprehensive literature search was conducted on PubMed using terms related to PNES and non-epileptic seizures.
  • Filters included human subjects, ages 1-18 years, English language, and publication dates from 2004-2019.
  • A total of 54 articles were reviewed, including those identified through cross-referencing.

Main Results:

  • Most studies on pediatric PNES were retrospective.
  • Clinical features, predisposing factors, and diagnostic workup for pediatric PNES were detailed.
  • No consensus exists on psychiatric comorbidities, and no controlled treatment trials are available for pediatric PNES, though cognitive behavioral therapy is standard for adults.

Conclusions:

  • Pediatric PNES appear to have better outcomes compared to adult cases.
  • There is a critical need for long-term prospective studies to better understand the clinical features, outcomes, and comorbid conditions associated with pediatric and adolescent PNES.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
903
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
801
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
667
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
415
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
913
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.2K